about
Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentialityCoexpression and coregulation analysis of time-series gene expression data in estrogen-induced breast cancer cellIn vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein.The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells.A generic cycling hypoxia-derived prognostic gene signature: application to breast cancer profiling.The role of cytokines in breast cancer development and progressionHypoxia Up-Regulates Galectin-3 in Mammary Tumor Progression and Metastasis.Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay.Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissueHIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer.The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Role of carbohydrate response element-binding protein (ChREBP) in generating an aerobic metabolic phenotype and in breast cancer progression.The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.Tumour oxygenation: implications for breast cancer prognosis.Tissue Stiffness and Hypoxia Modulate the Integrin-Linked Kinase ILK to Control Breast Cancer Stem-like Cells.Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma.Designing a Microfluidic Device with Integrated Ratiometric Oxygen Sensors for the Long-Term Control and Monitoring of Chronic and Cyclic Hypoxia.Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistance.Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines.HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions.Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis.Identification of functional metabolic biomarkers from lung cancer patient serum using PEP technology.Mixed lineage leukaemia-4 regulates cell-cycle progression and cell viability and its depletion suppresses growth of xenografted tumour in vivo.CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma
P2860
Q27025007-CB8BDB34-DE95-4B34-B70F-54185D2C3805Q30605508-82EA8FA1-57F2-47ED-B5EA-9EDB70130B62Q33805335-4FAE674A-159B-42D9-94DA-1F394BDC33CBQ34123758-52321391-9719-45C0-9E18-E8AEA5F62D82Q34324438-12A1DCA8-17F3-4842-8A2A-AEB3B0605850Q34334455-66168FA0-FEA3-4F75-BDE0-13E2D8DD91A7Q34920381-EA2D1AF4-61D8-4593-84E3-6591535C6CCDQ35723085-E6CB6669-4362-408D-8000-A65A62C08970Q36144177-C2086A6F-5F51-4A6E-AE1F-50DF4FB5537AQ36243405-CAB3FA87-2ABE-4312-9F33-D657E1B3DCEAQ36300305-6E4BAAFE-1D4B-43ED-90F4-4C1D8923EA8AQ36353524-0F957444-5F7F-4DAC-BE5A-548FD0E79B38Q37210542-59E281E5-60C6-41CD-ABDD-48C1EABAEA3EQ37533025-772E4D98-C7DB-41A3-82F1-C906B12C882BQ37559035-017C0C6B-547E-4007-B5CD-DC586AC515EEQ37599071-F485A069-27C2-43E8-B6E5-723C9E58984DQ38120823-EE1E4D6A-6BE9-4C50-8FD1-6E7C198C541AQ38752916-375507E8-CD73-42FB-B2CA-7AEA194B2A86Q38804116-1176DA1F-9CBD-4FE2-BB67-4D9D476BF56FQ38842641-A43AEC6D-F050-48ED-80F6-FF41E9764A41Q38957845-D6511143-5798-4182-A73D-28000A0EC0C9Q39068877-A24FA635-24D0-4DDE-92CB-3E1E2851EDDDQ39113716-4D8E1D19-C8BB-4410-ADC5-884B483DCECAQ39262277-CDA13E84-3B72-4005-AC51-9D279614D6BBQ41968203-EE0281EF-C8CD-44AE-8A07-664AE2E9CB13Q42234071-B0037C99-A23F-4D22-B286-E7D73EA44469Q58710754-CD5E7F0F-6BCA-40A9-8808-3665F238ADA7
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Gene expression and hypoxia in breast cancer.
@ast
Gene expression and hypoxia in breast cancer.
@en
type
label
Gene expression and hypoxia in breast cancer.
@ast
Gene expression and hypoxia in breast cancer.
@en
prefLabel
Gene expression and hypoxia in breast cancer.
@ast
Gene expression and hypoxia in breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Gene expression and hypoxia in breast cancer.
@en
P2093
Elena Favaro
Francesca M Buffa
Simon Lord
P2860
P2888
P356
10.1186/GM271
P577
2011-08-26T00:00:00Z
P5875
P6179
1035267092